Danielle Antalffy

Stock Analyst at UBS

(1.49)
# 1546
Out of 5,331 analysts
221
Total ratings
46.51%
Success rate
6.41%
Average return
43 Stocks
Name Action PT Current % Upside Ratings Updated
ATRC AtriCure
Maintains: Buy
60 58
30 93.33% 13 Apr 30, 2025
INMD InMode
Maintains: Neutral
19 17
14.57 11.53% 4 Apr 29, 2025
RXST RxSight
Downgrades: Neutral
45 16
15.9 0.63% 3 Apr 9, 2025
MDT Medtronic
Maintains: Neutral
85 95
84.62 12.27% 8 Feb 19, 2025
BSX Boston Scientific
Maintains: Strong Buy
105 130
104.88 23.95% 11 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 5
3.06 63.4% 2 Jan 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
146 148
132.98 11.29% 12 Jan 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
182
87.32 108.43% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
366 370
377.92 -2.1% 6 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
90 75
75.55 -0.73% 12 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
112 107
102 4.9% 4 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 7
7.29 -3.98% 5 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
163 95
81.66 16.34% 8 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
35.27 112.65% 1 Jan 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
180
156.03 15.36% 4 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
218
n/a n/a 4 Sep 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
405 322
159.1 102.39% 5 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
3
2.31 -2.6% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
43
30.66 40.25% 5 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
278
529.29 -47.48% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
45
21.47 109.59% 14 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
160 140
n/a n/a 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
300 280
257.01 8.95% 12 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
975 825
12.24 6640.2% 2 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 20
n/a n/a 9 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 14
17.11 -18.18% 1 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
75 100
108.8 -8.09% 2 May 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 12
11.97 0.25% 3 Mar 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 30
55.61 -46.05% 3 Mar 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 65
n/a n/a 6 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 45
38.92 15.62% 4 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
105 85
n/a n/a 10 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 95
n/a n/a 6 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
270 275
168.32 63.38% 1 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
345 325
n/a n/a 12 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Market Perform
36 80
n/a n/a 1 Jan 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 20
5.25 280.95% 3 Nov 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
75 66
n/a n/a 4 Nov 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
72 42
7.2 483.33% 7 Nov 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
3
0.71 322.54% 3 Apr 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
15
0.94 1495.74% 1 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 75
n/a n/a 3 Oct 3, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Aug 22, 2017